1
|
Giulia R, Saliu F, Migliara A, Nicola F, Bragonzi A, Lombardo A, Cigana C, Cirillo D, Lore N. 508 Lack of interleukin-17 receptor C limits host resistance and sustains type 17 inflammation during chronic airway infection by Pseudomonas aeruginosa. J Cyst Fibros 2022. [DOI: 10.1016/s1569-1993(22)01198-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
2
|
Esposito A, Migliaccio A, Tupini C, D’Alonzo D, Lampronti I, Bragonzi A, Dechecchi M, De Gregorio E, Guaragna A. ePS3.07 Exploring the therapeutic potential of iminosugars as antibacterial and antibiofilm agents in the treatment of cystic fibrosis lung disease infections. J Cyst Fibros 2022. [DOI: 10.1016/s1569-1993(22)00305-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
3
|
Cigana C, Giannella R, Alcalá-Franco B, D’Aurora M, Colavolpe A, Giustra M, Bragonzi A. 468: Impact of CFTR modulators on antibiotic susceptibility and virulence of Pseudomonas aeruginosa and Staphylococcus aureus. J Cyst Fibros 2021. [DOI: 10.1016/s1569-1993(21)01892-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
4
|
Sipione B, Lorè N, Rossi G, Sanvito F, D’Aurora M, Neri A, Gianferro F, Cigana C, Bragonzi A. 674: ΔF508-CFTR mutation in genetically diverse collaborative cross mice expands CF disease-relevant phenotypes. J Cyst Fibros 2021. [DOI: 10.1016/s1569-1993(21)02097-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
5
|
Rizzo G, Saliu F, Migliara A, Bragonzi A, Lombardo A, Cigana C, Cirillo D, Lorè N. 461: Unraveling the role of IL-17 receptor C during development of airway chronic infections by Pseudomonas aeruginosa. J Cyst Fibros 2021. [DOI: 10.1016/s1569-1993(21)01885-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
6
|
Sipione B, Lorè N, Rossi G, Sanvito F, D'Aurora M, Bragonzi A. WS07.3 Phenotypic and genotypic characterisation of a novel mouse model of F508del-CFTR in genetically diverse collaborative cross. J Cyst Fibros 2021. [DOI: 10.1016/s1569-1993(21)00953-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
7
|
Bevivino A, Bacci G, Rossi A, Armanini F, Cangioli L, Segata N, Mengoni A, Bragonzi A. P142 Lung and gut microbiota signatures in cystic fibrosis mice challenged with Pseudomonas aeruginosa. J Cyst Fibros 2021. [DOI: 10.1016/s1569-1993(21)01168-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
8
|
Codagnone M, Cianci E, Lamolinara A, Mari VC, Nespoli A, Isopi E, Mattoscio D, Arita M, Bragonzi A, Iezzi M, Romano M, Recchiuti A. Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection. Mucosal Immunol 2018; 11:35-49. [PMID: 28422188 DOI: 10.1038/mi.2017.36] [Citation(s) in RCA: 74] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2016] [Accepted: 03/14/2017] [Indexed: 02/07/2023]
Abstract
Pseudomonas aeruginosa lung infection is a main cause of disability and mortality worldwide. Acute inflammation and its timely resolution are crucial for ensuring bacterial clearance and limiting tissue damage. Here, we investigated protective actions of resolvin (Rv) D1 in lung infection induced by the RP73 clinical strain of P. aeruginosa. RvD1 significantly diminished bacterial growth and neutrophil infiltration during acute pneumonia caused by RP73. Inoculum of RP73, immobilized in agar beads, resulted in persistent lung infection up to 21 days, leading to a non resolving inflammation reminiscent of human pathology. RvD1 significantly reduced bacterial titer, leukocyte infiltration, and lung tissue damage. In murine lung macrophages sorted during P. aeruginosa chronic infection, RvD1 regulated the expression of Toll-like receptors, downstream genes, and microRNA (miR)-21 and 155, resulting in reduced inflammatory signaling. In vitro, RvD1 enhanced phagocytosis of P. aeruginosa by neutrophils and macrophages, recapitulating its in vivo actions. These results unveil protective functions and mechanisms of action of RvD1 in acute and chronic P. aeruginosa pneumonia, providing evidence for its potent pro-resolution and tissue protective properties on airway mucosal tissue during infection.
Collapse
Affiliation(s)
- M Codagnone
- Department of Medical, Oral, and Biotechnology Science, University of Chieti-Pescara, Chieti, Italy.,Center on Aging Science and Translational Medicine (CeSI-MeT) "G. d'Annunzio", University of Chieti-Pescara, Chieti, Italy
| | - E Cianci
- Department of Medical, Oral, and Biotechnology Science, University of Chieti-Pescara, Chieti, Italy.,Center on Aging Science and Translational Medicine (CeSI-MeT) "G. d'Annunzio", University of Chieti-Pescara, Chieti, Italy
| | - A Lamolinara
- Center on Aging Science and Translational Medicine (CeSI-MeT) "G. d'Annunzio", University of Chieti-Pescara, Chieti, Italy.,Department of Medicine and Aging Science, University of Chieti-Pescara, Chieti, Italy
| | - V C Mari
- Center on Aging Science and Translational Medicine (CeSI-MeT) "G. d'Annunzio", University of Chieti-Pescara, Chieti, Italy
| | - A Nespoli
- Center on Aging Science and Translational Medicine (CeSI-MeT) "G. d'Annunzio", University of Chieti-Pescara, Chieti, Italy.,Department of Medicine and Aging Science, University of Chieti-Pescara, Chieti, Italy
| | - E Isopi
- Department of Medical, Oral, and Biotechnology Science, University of Chieti-Pescara, Chieti, Italy.,Center on Aging Science and Translational Medicine (CeSI-MeT) "G. d'Annunzio", University of Chieti-Pescara, Chieti, Italy
| | - D Mattoscio
- Department of Medical, Oral, and Biotechnology Science, University of Chieti-Pescara, Chieti, Italy.,Center on Aging Science and Translational Medicine (CeSI-MeT) "G. d'Annunzio", University of Chieti-Pescara, Chieti, Italy
| | - M Arita
- RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan
| | - A Bragonzi
- Infection and Cystic Fibrosis Unit, Division of Immunology, transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - M Iezzi
- Center on Aging Science and Translational Medicine (CeSI-MeT) "G. d'Annunzio", University of Chieti-Pescara, Chieti, Italy.,Department of Medicine and Aging Science, University of Chieti-Pescara, Chieti, Italy
| | - M Romano
- Department of Medical, Oral, and Biotechnology Science, University of Chieti-Pescara, Chieti, Italy.,Center on Aging Science and Translational Medicine (CeSI-MeT) "G. d'Annunzio", University of Chieti-Pescara, Chieti, Italy
| | - A Recchiuti
- Department of Medical, Oral, and Biotechnology Science, University of Chieti-Pescara, Chieti, Italy.,Center on Aging Science and Translational Medicine (CeSI-MeT) "G. d'Annunzio", University of Chieti-Pescara, Chieti, Italy
| |
Collapse
|
9
|
Lorè N, Sipione B, Mott R, Iraqi F, Bragonzi A. WS09.4 Novel disease models to capture pathological complexity of Pseudomonas aeruginosa respiratory infection. J Cyst Fibros 2017. [DOI: 10.1016/s1569-1993(17)30210-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
10
|
Cigana C, Bianconi I, De Simone M, Riva C, Baldan R, Sipione B, Cirillo D, Bragonzi A. 165 Modeling polymicrobial infections in the pathogenesis of cystic fibrosis lung disease. J Cyst Fibros 2017. [DOI: 10.1016/s1569-1993(17)30529-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
11
|
Cigana C, Lorè N, Riva C, De Fino I, Cariani L, Spagnuolo L, Sipione B, Rossi G, Colombo C, Bragonzi A. WS10.5 Pseudomonas aeruginosa adaptation as a potential risk factor to the progression of cystic fibrosis airway disease in mice and humans. J Cyst Fibros 2015. [DOI: 10.1016/s1569-1993(15)30066-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
12
|
Carnell SC, Perry JD, Vollmer D, Biboy J, Facchini M, Bragonzi A, Vergunst A, Vollmer W, Khan CMA, De Soyza A. S104 Targeting the bacterial cytoskeleton of CF pathogens for antimicrobial development–A cautionary tale? Thorax 2013. [DOI: 10.1136/thoraxjnl-2013-204457.111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
13
|
Lorè N, Cigana C, Riva C, De Fino I, Bragonzi A. WS11.4 Host response to Pseudomonas aeruginosa adaptation during airway chronic infection. J Cyst Fibros 2012. [DOI: 10.1016/s1569-1993(12)60078-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
14
|
Dubern JF, Cigana C, Lazenby J, De Simone M, Juhas M, Schwager S, Eberl L, Doring G, Williams P, Bragonzi A, Camara M. 86 Genome wide random screening strategy for the discovery of novel antimicrobial targets in Pseudomonas aeruginosa. J Cyst Fibros 2012. [DOI: 10.1016/s1569-1993(12)60256-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
15
|
Döring G, Bragonzi A, Ulrich M, Paroni M, Cigana C, Konstan M. WS17.2 Anti-inflammatory therapy in a mouse model of Pseusomonas aeruginosa lung infection leads to bacteraemia. J Cyst Fibros 2012. [DOI: 10.1016/s1569-1993(12)60120-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
16
|
Bergamini G, Mauri P, Cigana C, Di Silvestre D, Di Palma A, Bragonzi A, Assael B, Sorio C, Melotti P. Analysis of proteins released from Pseudomonas aeruginosa clinical and laboratory strains: effects of azithromycin. J Cyst Fibros 2009. [DOI: 10.1016/s1569-1993(09)60160-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
17
|
Bragonzi A, Döring G. EXPLOITING GENOMICS TO DEVELOP NEW ANTIBIOTICS AND VACCINES AGAINST CF-RELATED PATHOGENS. J Cyst Fibros 2008. [DOI: 10.1016/s1569-1993(08)60489-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
18
|
Bragonzi A, Paroni M, Montanari S, Oliver A, Döring G, Tümmler B. PSEUDOMONAS AERUGINOSA PATHOGENICITY WITHIN CLONAL STRAINS FROM PATIENTS WITH CYSTIC FIBROSIS. J Cyst Fibros 2008. [DOI: 10.1016/s1569-1993(08)60535-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
19
|
Abstract
Since Cystic Fibrosis (CF) is an autosomal recessive disorder due to mutations in the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene, studies towards a gene therapy approach to its treatment followed immediately upon the cloning of the gene. It was demonstrated that the insertion of a single copy of the wild-type gene restored the normal phenotype in CF cells in vitro. Encouraging results were obtained in many in vivo model systems (CF transgenic mice) involving viral as well as non-viral vectors, which demonstrated the recovery of CFTR function in the airways. These results constituted the basis for human studies. Of those with a non-viral approach, a total of seven clinical trials using cationic lipids have reported data on efficiency, efficacy and safety. An effective gene transfer approach for the treatment of CF lung disease is not however imminent: low transfection efficiency and poor maintenance of gene expression are so far the main obstacles on this therapeutic path. On the other hand, no important adverse effects have been documented and repeated administration in humans is possible. The understanding of tissue and cellular barriers is a prerequisite for the development of more efficient non-viral gene therapy protocols for CF patients. While cationic lipids have been shown to be blocked by the mucous airway barrier and not be able to transfect differentiated respiratory epithelial cells, a new class of non-viral vectors, cationic polymers, are endowed with chemical and biological properties that make them more efficient in mediating gene transfer than lipids. Cationic polymers, such as polyethylenimine, are promising vectors for CF lung gene therapy.
Collapse
Affiliation(s)
- A Bragonzi
- Institute for Experimental Treatment of Cystic Fibrosis, H.S. Raffaele Scientific Institute, Via Olgettina 58, 20132 Milano, Italy
| | | |
Collapse
|
20
|
Boletta A, Qian F, Onuchic LF, Bragonzi A, Cortese M, Deen PM, Courtoy PJ, Soria MR, Devuyst O, Monaco L, Germino GG. Biochemical characterization of bona fide polycystin-1 in vitro and in vivo. Am J Kidney Dis 2001; 38:1421-9. [PMID: 11728985 DOI: 10.1053/ajkd.2001.29282] [Citation(s) in RCA: 41] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
The most common form of autosomal dominant polycystic kidney disease (PKD) results from mutation of the PKD1 gene on chromosome 16p13.3. The gene encodes a 14-kb messenger RNA that is predicted to express a 462-kd membrane protein. The gene product, polycystin-1, has a large extracellular portion composed of a novel combination of protein-protein interacting domains and is postulated to be a plasma membrane receptor involved in cell-cell/matrix interactions. However, slow progress has been made in the characterization of polycystin-1 or the determination of its function. In fact, the protein is expressed at very low levels in tissues and cell lines and previous efforts directed at expression of recombinant protein had been largely unsuccessful. We have recently developed constructs of full-length human PKD1 complementary (cDNA) that can be expressed in both a stable and transient fashion in mammalian cells. We used these systems to characterize our antibodies and to track the protein in vivo. We report here the first biochemical characterization of recombinant polycystin-1 and show that the protein is a 520-kd glycosylated polypeptide with an unglycosylated core of 460 kd. Subcellular fractionation as well as biotinylation studies confirmed that the protein is plasma-membrane associated. Furthermore, we show that the recombinant protein localizes to cell-cell junctions in polarized madin darby canine kidney cells as revealed by indirect immunofluorescence. Our data represent the first characterization of polycystin-1 performed under highly controlled conditions.
Collapse
Affiliation(s)
- A Boletta
- Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Bragonzi A, Dina G, Villa A, Calori G, Biffi A, Bordignon C, Assael BM, Conese M. Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs. Gene Ther 2000; 7:1753-60. [PMID: 11083497 DOI: 10.1038/sj.gt.3301282] [Citation(s) in RCA: 113] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Biodistribution of nonviral cationic vector/DNA complexes was studied after systemic or intratracheal administration to the lungs and correlated with transgene expression. Intravenous injection in C57Bl/6 mice gave maximal and significant luciferase expression in the lungs with the cationic polymer PEI 22K/DNA complexes at the highest ratios of positive/negative charges versus DNA alone. While DOTAP/DNA complexes with high charge ratio determined lower but still significant luciferase activity versus uncomplexed DNA, GL-67A and PEI 25K mediated negligible luciferase expression. Labelled PEI 22K and DOTAP complexes were evenly distributed in the alveolar region, where GFP expression was revealed, while PEI 25K and GL-67A complexes were not detected, suggesting a different interaction of these complexes with the plasma membrane of endothelial cells. Following an intratracheal injection, the highest and significant levels of transfection were obtained with slightly positive PEI complexes as compared with DNA alone, whereas cationic lipid-based vectors, DOTAP and GL-67A, gave not significant luciferase activity. Both types of polyplexes gave similar levels of lung luciferase expression by targeting different airway cell populations. PEI 25K complexes determined high levels of GFP in the bronchial cells, confirming confocal data on fluorescent complexes internalization. PEI 22K complexes gave mainly high GFP signal in the distal tract of the bronchial tree, where tagged complexes were recovered. Fluorescent lipid complexes were found in aggregates in the lumen of bronchi totally (DOTAP) or partially (GL-67A) co-localizing with surfactant protein A. Results indicated that cationic polymers could overcome the surfactant barrier which inhibited airway cell transfection mediated by cationic lipids.
Collapse
Affiliation(s)
- A Bragonzi
- Institute for Experimental Treatment of Cystic Fibrosis, San Raffaele Scientific Institute, Milano, Italy
| | | | | | | | | | | | | | | |
Collapse
|
22
|
Bragonzi A, Distefano G, Buckberry LD, Acerbis G, Foglieni C, Lamotte D, Campi G, Marc A, Soria MR, Jenkins N, Monaco L. A new Chinese hamster ovary cell line expressing alpha2,6-sialyltransferase used as universal host for the production of human-like sialylated recombinant glycoproteins. Biochim Biophys Acta 2000; 1474:273-82. [PMID: 10779678 DOI: 10.1016/s0304-4165(00)00023-4] [Citation(s) in RCA: 74] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Chinese hamster ovary (CHO) cells are widely employed to produce glycosylated recombinant proteins. Our group as well as others have demonstrated that the sialylation defect of CHO cells can be corrected by transfecting the alpha2,6-sialyltransferase (alpha2,6-ST) cDNA. Glycoproteins produced by such CHO cells display both alpha2,6- and alpha2,3-linked terminal sialic acid residues, similar to human glycoproteins. Here, we have established a CHO cell line stably expressing alpha2,6-ST, providing a universal host for further transfections of human genes. Several relevant parameters of the universal host cell line were studied, demonstrating that the alpha2,6-ST transgene was stably integrated into the CHO cell genome, that transgene expression was stable in the absence of selective pressure, that the recombinant sialyltransferase was correctly localized in the Golgi and, finally, that the bioreactor growth parameters of the universal host were comparable to those of the parental cell line. A second step consisted in the stable transfection into the universal host of cDNAs for human glycoproteins of therapeutic interest, i.e. interferon-gamma and the tissue inhibitor of metalloproteinases-1. Interferon-gamma purified from the universal host carried 40.4% alpha2,6- and 59.6% alpha2,3-sialic acid residues and showed improved pharmacokinetics in clearance studies when compared to interferon-gamma produced by normal CHO cells.
Collapse
Affiliation(s)
- A Bragonzi
- DIBIT, Department of Biological and Technological Research, San Raffaele Scientific Institute, via Olgettina 58, 20132 Milan, Italy
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Foglieni C, Bragonzi A, Cortese M, Cantù L, Boletta A, Chiossone I, Soria MR, Monaco L. Glomerular filtration is required for transfection of proximal tubular cells in the rat kidney following injection of DNA complexes into the renal artery. Gene Ther 2000; 7:279-85. [PMID: 10694807 DOI: 10.1038/sj.gt.3301092] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Gene transfer to the kidney can be achieved with various DNA vectors, resulting in transgene expression in glomerular or tubular districts. Controlling transgene destination is desirable for targeting defined renal cells for specific therapeutic purposes. We previously showed that injection of polyplexes into the rat renal artery resulted in transfection of proximal tubular cells. To investigate whether this process involves glomerular filtration of the DNA-containing particles, fluorescent polyethylenimine polyplexes were prepared, containing fluoresceinated poly-L-lysine. This allowed visualization of the route of the particles into the kidney. Our polyplexes were filtered through the glomerulus, since fluorescent proximal tubuli were observed. Conversely, fluorescent lipopolyplexes containing the cationic lipid DOTAP were never observed in tubular cells. Size measurements by laser light scattering showed that the mean diameter of polyplexes (93 nm) was smaller than that of lipopolyplexes (160 nm). The size of the transfecting particles is therefore a key parameter in this process, as expected by the constraints imposed by the glomerular filtration barrier. This information is relevant, in view of modulating the physico-chemical properties of DNA complexes for optimal transgene expression in tubular cells. Gene Therapy (2000) 7, 279-285.
Collapse
Affiliation(s)
- C Foglieni
- Biotechnology Unit, Dibit, Department of Biological and Technological Research, San Raffaele Scientific Institute, Milan, Italy
| | | | | | | | | | | | | | | |
Collapse
|
24
|
Bragonzi A, Boletta A, Biffi A, Muggia A, Sersale G, Cheng SH, Bordignon C, Assael BM, Conese M. Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs. Gene Ther 1999; 6:1995-2004. [PMID: 10637451 DOI: 10.1038/sj.gt.3301039] [Citation(s) in RCA: 114] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Airway inflammation frequently found in congenital and acquired lung diseases may interfere with gene delivery by direct administration through either instillation or aerosol. Systemic delivery by the intravenous administration represents an alternative route of delivery that might bypass this barrier. A nonviral approach for transfecting various airway-derived cell lines in vitro showed that cationic polymers (PEI 22K and 25K) and lipids (DOTAP, GL-67/DOPE) are able to transfect with high efficiency the reporter genes firefly luciferase and E. coli lacZ. Notably, two properties predicted that cationic vectors would be useful for a systemic gene delivery approach to the lung: (1) transfection was not inhibited or increased when cells were incubated with cationic lipids or polymers in the presence of serum; and (2) cationic vectors protected plasmid DNA from DNase degradation. A single injection of DNA complexed to the cationic polymer PEI 22K into the tail vein of adult mice efficiently transfected primarily the lungs and to a lesser extent, heart, spleen, kidney and liver. The other vectors mediated lower to undetectable levels of luciferase expression in the lungs, with DOTAP > GL67/DOPE > PEI 25K > DOTMA/DOPE. A double injection protocol with a 15-min interval between the two doses of DOTAP/DNA complexes was investigated and showed a relevant role of the first injection in transfecting the lungs. A two log increase in luciferase expression was obtained either when the two doses were comprised of luciferase plasmid or when an irrelevant plasmid was used in the first injection. The double injection of luciferase/PEI 22K complexes determined higher transgene levels than a single dose, but a clear difference using an irrelevant plasmid as first dose was not observed. Using lacZ as a reporter gene, it was shown that only cells in the alveolar region, including type II penumocytes, stained positively for the transgene product.
Collapse
Affiliation(s)
- A Bragonzi
- Telethon Institute for Gene Therapy, San Raffaele Scientific Institute, Milano, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Monaco L, Tagliabue R, Giovanazzi S, Bragonzi A, Soria MR. Expression of recombinant human granulocyte colony-stimulating factor in CHO dhfr- cells: new insights into the in vitro amplification expression system. Gene 1996; 180:145-50. [PMID: 8973359 DOI: 10.1016/s0378-1119(96)00435-0] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
The in vitro amplification method for heterologous gene expression in mammalian cells is based on the stable transfection of cells with long, linear DNA molecules having several copies of complete expression units, coding for the gene of interest, linked to one terminal unit, coding for the selectable marker. DNA concatenamers containing additional expression units can also be prepared: we exploited this feature by co-polymerizing expression units coding for granulocyte colony-stimulating factor (G-CSF) with cassettes for dihydrofolate reductase (DHFR) and for neomycin (Nm) resistance, as selectable markers. We were thus able to obtain high level production of G-CSF in chinese hamster ovary (CHO) dhfr- cells by combining in vitro amplification to just one step of in vivo amplification. This approach required a considerably shorter time than the classical, stepwise amplification by methotrexate.
Collapse
Affiliation(s)
- L Monaco
- Biotechnology Unit, DIBIT, San Raffaele Scientific Institute, Milano, Italy.
| | | | | | | | | |
Collapse
|